0001209191-22-057984.txt : 20221118 0001209191-22-057984.hdr.sgml : 20221118 20221118184009 ACCESSION NUMBER: 0001209191-22-057984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221116 FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEPHENSON BRIAN C CENTRAL INDEX KEY: 0001780030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 221403151 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001780030 STEPHENSON BRIAN C C/O BRIDGEBIO PHARMA, INC. 421 KIPLING ST. PALO ALTO CA 94301 0 1 0 0 Secretary, Treasurer & CFO Common Stock 2022-11-16 4 M 0 30467 A 371731 D Common Stock 2022-11-16 4 F 0 10789 9.64 D 360942 D Common Stock 2022-11-17 4 S 0 19678 9.4006 D 341264 D Restricted Stock Units 2022-11-16 4 M 0 1710 0.00 D Common Stock 1710 10259 D Restricted Stock Units 2022-11-16 4 M 0 778 0.00 D Common Stock 778 7003 D Restricted Stock Units 2022-11-16 4 M 0 24193 0.00 D Common Stock 24193 120965 D Restricted Stock Units 2022-11-16 4 M 0 3786 0.00 D Common Stock 3786 11358 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Includes 4 shares acquired by the Reporting Person on August 15, 2022 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 30,467 shares of Common Stock underlying the Reporting Person's RSUs. Represents the weighted average sale price of the shares sold from $9.14 to $9.64 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein. The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. The RSUs will vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. /s/ Brian C. Stephenson 2022-11-18